Skip to main content

Table 3 Relative abundance of fungal genera of colonic samples

From: Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

Fungal taxa Sham SBS GLP2.SBS
Eurotiomycetes.C
 Aspergillus.G 16.43 (6.48) 5.36 (1.61) ** 9.14 (2.99)
 Penicillium.G 2.46 (1.07) 0.41 (0.16) ** 1.75 (0.65) #
 Xerochrysium.G 0.00 (0.00–0.03) 0.31 (0.10–0.75) * 0.11 (0.03–0.50)
Saccharomycetes.C
 Wickerhamomyces.G 7.41 (2.27) 3.33 (1.62) * 4.12 (1.63)
 Debaryomyces.G 0.00 (0.00–0.17) 3.90 (2.43–7.56) ** 0.30 (0.17–0.37) #
 Meyerozyma.G 4.66 (1.51) 13.51 (5.27) ** 1.48 (0.26) ###
  1. Data were expressed as percentages of total sequences. For data passed normality test, one-way ANOVA and Tukey’s multiple comparisons test were used, and data were shown as mean (SD). Otherwise, Kruskal-Wallis and Dunn’s multiple comparisons test were used, and data were shown as median and IQR
  2. .C Class, G Genus
  3. *P < 0.05; **P < 0.01 compared with Sham group; #P < 0.05; ###P < 0.001 compared with SBS group